Prescribing Axsain®
Axsain® (capsaicin cream 0.075%)
Therapeutic indications
Axsain® (capsaicin cream 0.075%) is indicated:
- For the symptomatic relief of neuralgia associated with and following Herpes Zoster infections (post-herpetic neuralgia) after open skin lesions have healed
- For the symptomatic management of painful diabetic peripheral polyneuropathy1
About Axsain®
Axsain® (capsaicin cream 0.075%) is for topical application1
Capsaicin binds to skin-based nociceptors, initially causing localised neurogenic inflammation then cumulatively depleting inflammatory agents including Substance P.1
For the full list of excipients, see Section 6.1 of the Summary of Product Characteristics.
Marketing Authorisation
Cephalon UK Limited
Ridings Point, Whistler Drive
Castleford, West Yorkshire
WF10 5HX
United Kingdom
Marketing Authorisation Number(s)
- PL 16260/0016
Resources for Axsain®
Medicine supporting documentation for Axsain®
-
Summary of Product Characteristics - Axsain® (capsaicin)
View Document > -
Patient Information Leaflet - Axsain® (capsaicin)
View Document >
1 Axsain® (capsaicin cream 0.075%) Summary of Product Characteristics.
Registered in England No. 302461.
Registered office: Teva UK Limited, Ridings Point, Whistler Drive, Castleford, WF10 5HX United Kingdom A0322
